TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
DYN

Dyne Therapeutics Inc

Healthcare · Biotechnology

16.50$ +1.7% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement DYN
Line item 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +14.4% -30.5% -5.9% -31.8% -99.8% +0.0% +48,766.7% -42.6% +62.2% -63.0% -100.0% – – – – – – –
– -7.9% -35.6% -1.1% -18.5% -72.2% +327.2% +0.0% +77.1% +12.5% +28.5% -100.0% +1,029.2% +158.3% +55.4% +207.4% -26.4% -8.9% -8.6%
– +55.6% -24.9% -10.4% -45.5% -142.6% – – -469.5% – – – – – – – – – –
– – – – – – – – – – – – +158.1% +309.4% +168.4% +17.7% +47.6% +33.5% +41.6%
– -22.7% +1.3% +2.5% -17.2% -83.7% +340.9% +0.0% +32.0% +25.8% +17.4% -99.7% +438.9% +382.7% +113.6% -1.8% +11.3% +99.0% +11.8%
– – – – -17.2% -160.0% – -417.5% – +25.8% +17.4% -97.5% +188.3% +324.2% +155.8% +14.0% +40.2% +42.5% +36.4%
– +17.2% -217.6% – – – -144.5% – – -1,100.0% – – – – – – – – –
– +11.2% -2.8% -12.5% -1.7% -100.0% – -30.9% +714.9% +14.5% -1.4% -100.0% +5,700.0% +36.6% +87.4% +293.1% -100.0% – –
– -7.9% -650.8% – – – -579.3% – – – – – – – – – – – –
– – – -37.5% -420.8% – – – -505.1% – – – – – – – – – –
– -34.1% -825.3% – – – -509.2% – – -2,580.0% – -106.3% – – – – – – –
– +8.7% -119.2% – -314.4% – +32.7% +94.7% +152.1% -85.6% +795.3% -100.5% – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?